Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

677 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study.
Ali AS, Lombardo J, Niazi MZ, Miller RC, Alnahhas I, Martinez NL, Andrews DW, Judy KD, Shi W. Ali AS, et al. Among authors: miller rc. J Neurooncol. 2022 Nov;160(2):345-350. doi: 10.1007/s11060-022-04146-w. Epub 2022 Nov 10. J Neurooncol. 2022. PMID: 36355259 Clinical Trial.
Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma.
Miller R, Song A, Ali A, Niazi M, Bar-Ad V, Martinez N, Glass J, Alnahhas I, Andrews D, Judy K, Evans J, Farrell C, Werner-Wasik M, Chervoneva I, Ly M, Palmer J, Liu H, Shi W. Miller R, et al. Front Oncol. 2022 Apr 29;12:896246. doi: 10.3389/fonc.2022.896246. eCollection 2022. Front Oncol. 2022. PMID: 35574391 Free PMC article.
Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial.
Miller R, Castillo R, Castillo E, Jones BL, Miften M, Kavanagh B, Lu B, Werner-Wasik M, Ghassemi N, Lombardo J, Barta J, Grills I, Rusthoven CG, Guerrero T, Vinogradskiy Y. Miller R, et al. Adv Radiat Oncol. 2022 Nov 30;8(2):101133. doi: 10.1016/j.adro.2022.101133. eCollection 2023 Mar-Apr. Adv Radiat Oncol. 2022. PMID: 36618762 Free PMC article.
Prospective trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life Report.
Lombardo J, Castillo E, Castillo R, Miller R, Jones B, Miften M, Kavanagh B, Dicker A, Boyle C, Leiby B, Banks J, Simone NL, Movsas B, Grills I, Guerrero T, Rusthoven CG, Vinogradskiy Y. Lombardo J, et al. Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00476-0. doi: 10.1016/j.ijrobp.2024.03.046. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38614278
Changes in post-treatment cardiac PET avidity predict overall survival in lung cancer patients treated with chemoradiation: Secondary analysis of the ACRIN 6668/RTOG 0235 clinical trial.
Miller R, Santangelo T, Forghani-Arani F, Rusthoven C, Chen Y, Castillo E, Castillo R, Guerrero T, Vinogradskiy Y. Miller R, et al. Radiother Oncol. 2022 Jun;171:22-24. doi: 10.1016/j.radonc.2022.04.003. Epub 2022 Apr 10. Radiother Oncol. 2022. PMID: 35413391 Free PMC article.
677 results